Navigation Links
Vaporized Propylene Glycol, a Key Ingredient in Electronic Cigarettes, May Prevent Pneumonia, Influenza, and Other Respiratory Diseases
Date:11/2/2009

Inhalation of vaporized propylene glycol, the primary ingredient in the electronic cigarette cartridge, may prevent pneumonia, influenza, and other respiratory diseases. These findings are based on a recently re-discovered study conducted by Dr. Oswald Hope Robertson of the University of Chicago's Billings Hospital in 1942 on inhalation of vaporized propylene glycol in laboratory mice.

(PRWEB) November 2, 2009 -- The ingredients in most electronic cigarette cartridges manufactured today include propylene glycol, nicotine, and a flavoring. The 1942 study by Dr. Oswald Hope Robertson of the University of Chicago's Billings Hospital showed that Propylene glycol, the most prevalent ingredient in electronic cigarette cartridges, was found to possibly prevent pneumonia, influenza, and other respiratory diseases when vaporized and inhaled.

Additional studies in monkeys and other animals were undertaken to determine long-term effects, especially the potential for accumulation in the lungs. After a few months of treatment, no ill effects were discovered.

Now the electronic cigarette may not only help individuals to reduce and quit smoking regular cigarettes, but it also may help to prevent some of the respiratory diseases caused by the harmful “cancer sticks”. Additionally with the pandemic H1N1 influenza virus expected to cause a record number of deaths this season there is no better time for smokers to cut back or quit with the aid of the electronic cigarette.

Electronic cigarettes are a relatively new tool in the battle against cigarette smoking. A smoker can enjoy all the engrained habits of smoking; hand-to-mouth, throat hit, visual smoke, nicotine delivery, etc… with none of the negative effects of inhaling the dangerous smoke and 4000+ toxic chemicals created by smoking regular cigarettes.

While using electronic cigarettes as a smoking cessation device/method has not yet been evaluated by the FDA, several quit smoking non-profit organizations, like Action on Smoking and Health UK (ASH) an international antismoking & nonsmokers' rights organization have all but endorsed electronic cigarettes as a healthy and viable alternative to smoking.

To find the right electronic cigarette for you or a loved one visit the electronic cigarette review site.

About e-CigCompare.com
e-CigCompare.com provides unbiased electronic cigarette reviews, including images, video and articles, on major manufacturers electronic cigarettes. Also provided are a quit smoking savings calculator and quit meter images showing the number of days a user has been cigarette free all free of charge. Visit http://e-CigCompair.com today to find the right electronic cigarette for you.

###

Read the full story at http://www.prweb.com/releases/electronic-cigarette/quit-smoking/prweb3146724.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Vaporized viral vector shows promise in anti-cancer gene therapy
2. Raising the Bar on MonoPropyleneGlycol USP/EP
3. InVitria's Better Ingredients for Better Media to be Showcased at BPI '09
4. Video: Laughter is the Key Ingredient in FIZZYS LUNCH LAB, a New Health-Themed Web-Only Property Launching November 16 on PBSKIDSGO.org
5. Pharmacies Use Online Database to Stop the Sale of Illegal Amounts of Key Ingredient Used to Make Methamphetamines
6. Frost & Sullivan Honours Kemin Health With Global Weight Management Ingredients New Product Innovation Award
7. Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma
8. Reportlinker Adds World Markets for Fermentation Ingredients Report
9. Aging Population, Heightened Consumer Awareness Propel U.S. Bone and Joint Health Ingredients, Says Frost & Sullivan
10. Baking Soda May Be Key Ingredient for Kidney Patients
11. Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Vaporized Propylene Glycol, a Key Ingredient in Electronic Cigarettes, May Prevent Pneumonia, Influenza, and Other Respiratory Diseases
(Date:9/21/2017)... ... September 21, 2017 , ... SABRE is raising awareness about personal safety ... the end of November. , The Chicago, Illinois, based self-defense brand has been waiting ... about the ease of taking their personal safety into their own hands. , The ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional Communication:, ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing and ... compliance with FDA rules. , The FDA has issued two draft guidances that ...
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a consistent and ... departments have been awarded five-year accreditation status through the Public Health Accreditation ... served by a PHAB-accredited health department now extend to more than 203 ...
(Date:9/21/2017)... , ... September 21, 2017 , ... ... right or exercise more try taking a more holistic approach and use natural ... new Amazon essential oil collection is certified USDA guaranteeing that, the new line ...
(Date:9/21/2017)... Mass. (PRWEB) , ... September 21, 2017 , ... The ... children with autism, announced today the election of Yie-Hsin Hung to the Board of ... Hung join our Board of Directors. Ms. Hung is an invaluable addition to our ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
Breaking Medicine Technology: